NewsRx

Search our medical news database

Finance

LCA-Vision completes share repurchase plan, announces new share plan, increases dividend

Published in Medical Device Law Weekly, December 31st, 2006

LCA-Vision, Inc., (LCAV), a leading provider of laser vision correction services under the LasikPlus brand, announced that it recently completed its existing share repurchase plan.

Under the plan, the company repurchased a total of 1,000,000 shares between May 17, 2005-November 21, 2006 for approximately $38.5 million at an average price per share of $38.52. In addition, the board of directors authorized a new share repurchase plan, and increased the quarterly dividend payment.

At a recent meeting, the board of directors approved a new share repurchase plan under which up to $50 million of LCA-Vision common shares may be repurchased. As of September...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook